Skip to content

Preparing for psychedelic therapies in Australia

Paul Liknaitzky

October 18, 2022 DOI: 10.54377/ffa5-a9d3 via OpenAlex

Summary

AI-generated from the abstract

Psychedelic therapies are returning to clinical research and may soon re-enter medical care for mental illness, but substantial work remains before they are ready for widespread use. When combined with psychotherapy, substances such as psilocybin (from 'magic mushrooms') and MDMA (from 'ecstasy') show potential for treating mental health conditions.

Study at a glance

Characteristics Review
Interventions Psilocybin MDMA
Keywords Psychology
Key finding Psychedelic therapies combined with psychotherapy show potential for treating mental illness, but significant development is still needed.

Abstract

Psychedelic therapies have the potential to treat mental illness but there’s still a long way to go. After decades in the wilderness, psychedelic therapies are making a comeback into clinical research and are poised to re-enter medical care. When used alongside psychotherapy, drugs like psilocybin (found in ‘magic mushrooms’) and MDMA (found in ‘ecstasy’) have […]

Comments

No comments yet.

Log in to comment